Erythrocyte transaminase activity in human vitamin B 6  deficiency.
D000328:Adult; D001219:Aspartate Aminotransferases / Q000097:blood* / Q000378:metabolism; D003124:Colorimetry; D003677:Deficiency Diseases / Q000150:complications / Q000201:enzymology; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D008660:Metabolism / Q000187:drug effects; D009059:Mouth Diseases / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D009539:Nicotinic Acids; D009668:Nose Diseases / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D009747:Nutritional Physiological Phenomena; D010383:Pellagra / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D011736:Pyridoxine / Q000627:therapeutic use; D011773:Pyruvates; D012257:Riboflavin Deficiency / Q000150:complications; D012627:Sebaceous Glands / Q000503:physiopathology; D012959:Socioeconomic Factors; D013268:Stimulation, Chemical; D026681:Vitamin B 6 Deficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000201:enzymology*
D009539:Nicotinic Acids; D011773:Pyruvates; D011732:Pyridoxal Phosphate; D001219:Aspartate Aminotransferases; D011736:Pyridoxine